These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9657560)

  • 1. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
    Noonan MJ; Chervinsky P; Brandon M; Zhang J; Kundu S; McBurney J; Reiss TF
    Eur Respir J; 1998 Jun; 11(6):1232-9. PubMed ID: 9657560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
    Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
    J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
    Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
    Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
    Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
    Zhang J; Yu C; Noonan G; Reiss TF
    Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
    Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
    J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
    Knorr B; Matz J; Bernstein JA; Nguyen H; Seidenberg BC; Reiss TF; Becker A
    JAMA; 1998 Apr; 279(15):1181-6. PubMed ID: 9555757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
    Yurdakul AS; Taci N; Eren A; Sipit T
    Respir Med; 2003 Dec; 97(12):1313-9. PubMed ID: 14682413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
    Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
    Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
    Vaquerizo MJ; Casan P; Castillo J; Perpiña M; Sanchis J; Sobradillo V; Valencia A; Verea H; Viejo JL; Villasante C; Gonzalez-Esteban J; Picado C;
    Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
    Baumgartner RA; Martinez G; Edelman JM; Rodriguez Gomez GG; Bernstein M; Bird S; Angner R; Polis A; Dass SB; Lu S; Reiss TF;
    Eur Respir J; 2003 Jan; 21(1):123-8. PubMed ID: 12570120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.
    Dockhorn RJ; Baumgartner RA; Leff JA; Noonan M; Vandormael K; Stricker W; Weinland DE; Reiss TF
    Thorax; 2000 Apr; 55(4):260-5. PubMed ID: 10722763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
    Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
    Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.